HUMAN IMMUNODEFICIENCY VIRUS 1 POSITIVE
Clinical trials for HUMAN IMMUNODEFICIENCY VIRUS 1 POSITIVE explained in plain language.
Never miss a new study
Get alerted when new HUMAN IMMUNODEFICIENCY VIRUS 1 POSITIVE trials appear
Sign up with your email to follow new studies for HUMAN IMMUNODEFICIENCY VIRUS 1 POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a cancer drug tame kaposi sarcoma in HIV patients?
Disease control CompletedThis completed Phase II trial tested the drug pomalidomide in 26 HIV-positive adults with Kaposi sarcoma, a type of skin cancer common in Sub-Saharan Africa. Pomalidomide works by boosting the immune system and blocking blood vessel growth that feeds tumors. Researchers measured …
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS 1 POSITIVE
Phase: PHASE2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Small study tracks daily life impact of kaposi sarcoma treatment
Knowledge-focused CompletedThis study followed 10 people with HIV and AIDS-related Kaposi sarcoma in Tanzania to see how their quality of life changed during treatment with vincristine and bleomycin. Participants filled out questionnaires about their physical, emotional, social, and daily functioning over …
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS 1 POSITIVE
Sponsor: AIDS Malignancy Consortium • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC